What It Is:

Each journey is grounded in behavioral insights and the real experiences of those who’ve been there.

Consistent, easy-to-understand education helps your patients feel prepared and confident from day one. The road to successful initiation begins before their first treatment and continues throughout those crucial early weeks and months when support matters most.

Why It Matters:

Each journey provides scalable patient education to support your hub teams. Not only do these programs reduce early drop-off and improve therapy initiation, but they also seamlessly connect with our downstream mentorship/peer programs through our Patient Experience Engine.

How It Works:

Each journey is custom-designed with your team to guide patients through what to expect. Delivered through reverbaBRIDGE, we show patients how to get started by reinforcing key information from you and HCPs to normalize their new routine. We provide support through the early stages to build the self-efficacy they’ll need to stay on course.

Ready to build a science-led, human-focused Onboarding Journey?


The Latest

  • Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes
    Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes

    At Patients as Partners 2026, CEO Cheryl Lubbert shared how sustaining patient engagement through organizational change requires intentional design, with systems built to hold as teams, priorities, and programs shift.

  • Pharma USA 2026: AI Scales Reach in Pharma. But What Actually Changes Patient and HCP Behavior?
    Pharma USA 2026: AI Scales Reach in Pharma. But What Actually Changes Patient and HCP Behavior?

    AI is becoming a baseline expectation in pharma. At Pharma USA 2026, discussions reflected less focus on whether AI should be used and more on how it is being applied…

  • Approval Is Not the Finish Line: Turning Late-Stage Clinical Evidence Into Real-World Impact
    Approval Is Not the Finish Line: Turning Late-Stage Clinical Evidence Into Real-World Impact

    Late-stage clinical programs establish the evidence required for regulatory evaluation, but they do not guarantee adoption, access, or commercial performance. Translating that evidence into real-world impact requires patient-centered execution and…